Q&A
HOME > 게시판 > Q&A
Q&A

The Background of Flibanserin: From Development to FDA Authorization

페이지 정보

작성자 Lois 작성일23-07-09 18:26 조회191회 댓글0건

본문

2 years later on, in 2015, the FDA ultimately granted authorization for Flibanserin, noting it as the very first drug authorized to deal with HSDD in premenopausal females. Since its approval, Flibanserin has been a game-changer for ladies's wellness, specifically in the location of sex-related wellness. While Flibanserin might not have actually started as a drug planned to treat HSDD, its journey as well as eventual FDA approval have actually had a substantial impact on ladies's wellness.


Instead of dealing with clinical depression, the firm chose to check out Flibanserin's potential to deal with HSDD. Flibanserin first sought approval from the FDA in 2010. 2 years later, in 2015, the FDA ultimately approved approval for Health Blog Flibanserin, noting it as the first medicine authorized to deal with HSDD in premenopausal females. Because its approval, Flibanserin has been a game-changer for females's wellness, specifically in the area of sex-related health and wellness. Should you have any concerns relating to wherever and health blog also the way to make use of health blog, you are able to e mail us on our web page. While Flibanserin may not have begun as a medication intended to treat HSDD, its journey as well as ultimate FDA approval have actually had a substantial influence on females's health.

댓글목록

등록된 댓글이 없습니다.

상호명:(주)도부 | 대표자:김미옥 | 사업자등록번호:224-81-20732 | TEL:063-547-7747 | FAX:063-546-7743 | ADD:전라북도 김제시 순동산단길 179
E-mail:01197974800@hanmail.net | Copyrightsⓒ2016 (주)도부 All rights reserved.  개인정보취급방침